Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.

Mei Z, Liu Y, Liu C, Cui A, Liang Z, Wang G, Peng H, Cui L, Li C.

Br J Cancer. 2014 Mar 18;110(6):1595-605. doi: 10.1038/bjc.2014.46. Epub 2014 Feb 6. Review.

2.

The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.

Ling A, Edin S, Wikberg ML, Öberg Å, Palmqvist R.

Br J Cancer. 2014 May 13;110(10):2551-9. doi: 10.1038/bjc.2014.161. Epub 2014 Mar 27.

3.

Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.

Kim Y, Bae JM, Li G, Cho NY, Kang GH.

PLoS One. 2015 Apr 15;10(4):e0122183. doi: 10.1371/journal.pone.0122183. eCollection 2015.

4.

The clinical utility of the local inflammatory response in colorectal cancer.

Richards CH, Roxburgh CS, Powell AG, Foulis AK, Horgan PG, McMillan DC.

Eur J Cancer. 2014 Jan;50(2):309-19. doi: 10.1016/j.ejca.2013.09.008. Epub 2013 Oct 5.

PMID:
24103145
5.

The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis.

Mao Y, Qu Q, Chen X, Huang O, Wu J, Shen K.

PLoS One. 2016 Apr 13;11(4):e0152500. doi: 10.1371/journal.pone.0152500. eCollection 2016. Review.

6.

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.

Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S.

J Pathol. 2010 Dec;222(4):350-66. doi: 10.1002/path.2774. Review.

7.

Comment on 'Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis'.

Park JH, Roxburgh CS, McMillan DC.

Br J Cancer. 2014 Dec 9;111(12):2372. doi: 10.1038/bjc.2014.296. Epub 2014 Oct 28. No abstract available.

8.

Response to comment on 'Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis'.

Mei Z, Liu Y, Liu C, Cui L.

Br J Cancer. 2014 Dec 9;111(12):2372-3. doi: 10.1038/bjc.2014.285. Epub 2014 Oct 28. No abstract available.

9.

Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma.

Correale P, Rotundo MS, Botta C, Del Vecchio MT, Ginanneschi C, Licchetta A, Conca R, Apollinari S, De Luca F, Tassone P, Tagliaferri P.

Clin Cancer Res. 2012 Feb 1;18(3):850-7. doi: 10.1158/1078-0432.CCR-10-3186. Epub 2011 Dec 5.

10.

The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.

Horn T, Laus J, Seitz AK, Maurer T, Schmid SC, Wolf P, Haller B, Winkler M, Retz M, Nawroth R, Gschwend JE, Kübler HR, Slotta-Huspenina J.

World J Urol. 2016 Feb;34(2):181-7. doi: 10.1007/s00345-015-1615-3. Epub 2015 Jun 9.

PMID:
26055646
11.

Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.

Matsumoto H, Thike AA, Li H, Yeong J, Koo SL, Dent RA, Tan PH, Iqbal J.

Breast Cancer Res Treat. 2016 Apr;156(2):237-47. doi: 10.1007/s10549-016-3743-x. Epub 2016 Mar 9.

PMID:
26960711
12.

The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.

Roxburgh CS, McMillan DC.

Cancer Treat Rev. 2012 Aug;38(5):451-66. doi: 10.1016/j.ctrv.2011.09.001. Epub 2011 Sep 25. Review.

PMID:
21945823
13.

The in situ local immune response, tumour senescence and proliferation in colorectal cancer.

Roxburgh CS, Richards CH, Macdonald AI, Powell AG, McGlynn LM, McMillan DC, Horgan PG, Edwards J, Shiels PG.

Br J Cancer. 2013 Oct 15;109(8):2207-16. doi: 10.1038/bjc.2013.556. Epub 2013 Sep 10.

14.

Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.

Amicarella F, Muraro MG, Hirt C, Cremonesi E, Padovan E, Mele V, Governa V, Han J, Huber X, Droeser RA, Zuber M, Adamina M, Bolli M, Rosso R, Lugli A, Zlobec I, Terracciano L, Tornillo L, Zajac P, Eppenberger-Castori S, Trapani F, Oertli D, Iezzi G.

Gut. 2017 Apr;66(4):692-704. doi: 10.1136/gutjnl-2015-310016. Epub 2015 Dec 30.

15.

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.

Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW.

Br J Cancer. 2011 Jun 28;105(1):93-103. doi: 10.1038/bjc.2011.189. Epub 2011 May 31. Review.

16.

CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A, Mantovani A, Roncalli M, Malesci A.

Lancet Oncol. 2009 Sep;10(9):877-84. doi: 10.1016/S1470-2045(09)70186-X. Epub 2009 Aug 3.

PMID:
19656725
17.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

PMID:
19022917
18.

Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.

Goeppert B, Frauenschuh L, Zucknick M, Stenzinger A, Andrulis M, Klauschen F, Joehrens K, Warth A, Renner M, Mehrabi A, Hafezi M, Thelen A, Schirmacher P, Weichert W.

Br J Cancer. 2013 Nov 12;109(10):2665-74. doi: 10.1038/bjc.2013.610. Epub 2013 Oct 17.

19.

Proliferation of T-cell subsets that contact tumour cells in colorectal cancer.

Golby SJ, Chinyama C, Spencer J.

Clin Exp Immunol. 2002 Jan;127(1):85-91.

20.

Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.

Berntsson J, Nodin B, Eberhard J, Micke P, Jirström K.

Int J Cancer. 2016 Sep 1;139(5):1129-39. doi: 10.1002/ijc.30138. Epub 2016 May 6.

PMID:
27074317

Supplemental Content

Support Center